Burden of meticillin-resistant Staphylococcus aureus infections at a Swiss University hospital: Excess length of stay and costs

Journal of Hospital Infection

Volumn 84, Issue 2, 2013, Pages 132-137

  Macedo Vinas M ^a   De Angelis, G ^b   Rohner, P ^a   Safran, E ^a   Stewardson, A ^a   Fankhauser, C ^a   Schrenzel, J ^a   Pittet, D ^a   Harbarth, S ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

Economics; Epidemiology; Health burden; Meticillin resistant Staphylococcus aureus; Multistate modelling

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; FEMALE; HEALTH ECONOMICS; HOSPITAL BED UTILIZATION; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HOSPITALIZATION; HOSPITALIZATION COST; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; UNIVERSITY HOSPITAL;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CROSS INFECTION; FEMALE; HEALTH CARE COSTS; HOSPITALS, UNIVERSITY; HUMANS; LENGTH OF STAY; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; STAPHYLOCOCCAL INFECTIONS; SWITZERLAND;

EID: 84878147150     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2013.02.015     Document Type: Article

References (24)

1. Filice G.A., Nyman J.A., Lexau C., et al. Excess costs and utilization associated with methicillin resistance for patients with Staphylococcus aureus infection. Infect Control Hosp Epidemiol 2010, 31:365-373.
2. Ott E., Bange F.C., Reichardt C., et al. Costs of nosocomial pneumonia caused by meticillin-resistant Staphylococcus aureus. JHosp Infect 2010, 76:300-303.
3. Cosgrove S.E., Qi Y., Kaye K.S., Harbarth S., Karchmer A.W., Carmeli Y. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, andhospital charges. Infect Control Hosp Epidemiol 2005, 26:166-174.
4. Engemann J.J., Carmeli Y., Cosgrove S.E., et al. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis 2003, 36:592-598.
5. de Kraker M.E., Wolkewitz M., Davey P.G., et al. Clinical impact of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay related to methicillin-resistant Staphylococcus aureus bloodstream infections. Antimicrob Agents Chemother 2011, 55:1598-1605.
6. Anderson D.J., Kaye K.S., Chen L.F., et al. Clinical and financial outcomes due to methicillin resistant Staphylococcus aureus surgical site infection: a multi-center matched outcomes study. PLoS One 2009, 4:e8305.
7. Graves N., Harbarth S., Beyersmann J., Barnett A., Halton K., Cooper B. Estimating the cost of health care-associated infections: mind your p's and q's. Clin Infect Dis 2010, 50:1017-1021.
8. Pada S.K., Ding Y., Ling M.L., et al. Economic and clinical impact of nosocomial meticillin-resistant Staphylococcus aureus infections in Singapore: a matched case-control study. JHosp Infect 2011, 78:36-40.
9. Perencevich E.N., Stone P.W., Wright S.B., Carmeli Y., Fisman D.N., Cosgrove S.E. Raising standards while watching the bottom line: making a business case for infection control. Infect Control Hosp Epidemiol 2007, 28:1121-1133.
10. Plowman R., Graves N., Griffin M.A., et al. The rate and cost of hospital-acquired infections occurring in patients admitted to selected specialties of a district general hospital in England and the national burden imposed. JHosp Infect 2001, 47:198-209.
11. Beyersmann J., Gastmeier P., Wolkewitz M., Schumacher M. An easy mathematical proof showed that time-dependent bias inevitably leads to biased effect estimation. JClin Epidemiol 2008, 61:1216-1221.
12. Beyersmann J., Kneib T., Schumacher M., Gastmeier P. Nosocomial infection, length of stay, and time-dependent bias. Infect Control Hosp Epidemiol 2009, 30:273-276.
13. Barnett A.G., Beyersmann J., Allignol A., Rosenthal V.D., Graves N., Wolkewitz M. The time-dependent bias and its effect on extra length of stay due to nosocomial infection. Value Health 2011, 14:381-386.
14. Beyersmann J., Gastmeier P., Grundmann H., et al. Transmission-associated nosocomial infections: prolongation of intensive care unit stay and risk factor analysis using multistate models. Am J Infect Control 2008, 36:98-103.
15. De Angelis G., Allignol A., Murthy A., et al. Multistate modelling to estimate the excess length of stay associated with meticillin-resistant Staphylococcus aureus colonisation and infection in surgical patients. JHosp Infect 2011, 78:86-91.
16. Aalen O.O., Johansen S. Empirical transition matrix for nonhomogeneous Markov-chains based on censored observations. Scand J Stat 1978, 5:10.
17. Datta S., Satten G.A. Validity of the Aalen-Johansen estimators of stage occupation probabilities and Nelson-Aalen estimators of integrated transition hazard for non-Markov models. Stat Probab Lett 2001, 55:9.
18. RFoundation for Statistical Computing. Alanguage and environment for statistical computing [program] 2004, R Foundation, Vienna.
19. Harbarth S., Sax H., Fankhauser-Rodriguez C., Schrenzel J., Agostinho A., Pittet D. Evaluating the probability of previously unknown carriage of MRSA at hospital admission. Am J Med 2006, 119:275.e15-275.e23.
20. Harris A.D., Carmeli Y., Samore M.H., Kaye K.S., Perencevich E. Impact of severity of illness bias and control group misclassification bias in case-control studies of antimicrobial-resistant organisms. Infect Control Hosp Epidemiol 2005, 26:342-345.
21. Huttner B., Robicsek A.A., Gervaz P., et al. Epidemiology of methicillin-resistant Staphylococcus aureus carriage and MRSA surgical site infections in patients undergoing colorectal surgery: a cohort study in two centers. Surg Infect 2012, 13:401-405.
22. Leal J.R., Laupland K.B. Validity of ascertainment of co-morbid illness using administrative databases: a systematic review. Clin Microbiol Infect 2010, 16:715-721.
23. Lee A.S., Macedo-Viñas M., Francois P., et al. Trends in mupirocin resistance in meticillin-resistant Staphylococcus aureus and mupirocin consumption at a tertiary care hospital. JHosp Infect 2011, 77:360-362.
24. Uçkay I., Lubbeke A., Harbarth S., et al. Low risk despite high endemicity of methicillin-resistant Staphylococcus aureus infections following elective total joint arthroplasty: a 12-year experience. Ann Med 2011, 44:9.